HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COMMON STOCK-FO
Total 13F shares
202,236,961
Share change
+457,108
Total reported value
$22,147,713,319
Put/Call ratio
33%
Price per share
$109.54
Number of holders
565
Value change
+$95,789,164
Number of buys
288
Number of sells
234

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q3 2021

As of 30 Sep 2021, HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by 565 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 202,236,961 shares. The largest 10 holders included VANGUARD GROUP INC, FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, Nuveen Asset Management, LLC, PAULSON & CO. INC., JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, STATE STREET CORP, and Bank of New York Mellon Corp. This page lists 566 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.